Why the study?
Fibrosis has traditionally been considered irreversible, but emerging evidence demonstrates that organ fibrosis can reverse under certain conditions, prompting a review of the mechanisms and therapeutic opportunities for fibrosis resolution.
Key points are not available for this paper at this time.
Design
Review
Organ fibrosis may be reversible via cell elimination and matrix clearance; leaves open whether these mechanisms can be therapeutically harnessed.
In pathological fibrosis, aberrant tissue remodeling with excess extracellular matrix leads to organ dysfunction and eventual morbidity. Diseases of fibrosis create significant global health and economic burdens and are often deadly. Although fibrosis has traditionally been thought of as an irreversible process, a growing body of evidence demonstrates that organ fibrosis can reverse in certain circumstances, especially if an underlying cause of injury can be removed. This body of evidence has uncovered more and more contributors to persistent and nonresolving tissue fibrosis. Here, we review the present knowledge on resolution of organ fibrosis and restoration of near-normal tissue architecture. We emphasize three critical areas of tissue homeostasis that are necessary for fibrosis resolution, namely, the elimination of matrix-producing cells, the clearance of excess matrix, and the regeneration of normal tissue constituents. In so doing, we also highlight how profibrotic pathways interact with one another and where there may be therapeutic opportunities to intervene and remediate pathological persistent fibrosis.
No takes yet. Share an insight, caveat, or question.
Atabai et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: